SER vs USB · rev $56.0K vs P/E 12, rev $28.66B
Serina Therapeutics Inc (SER) versus U.S. Bancorp (USB) — a side-by-side from cached financials, not a winner call.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
U.S. Bancorp (USB) is a banks - regional company listed on US.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
Latest reported USB revenue for 2025-12-31 was $28.66B. Net income was $7.57B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. USB currently screens at market cap $74.68B and trailing P/E 11.9.
SER currently screens at market cap $29.7M. USB currently screens at market cap $74.68B and trailing P/E 11.9.
Not investment advice. Open the SER and USB stock pages for the full models.
Not investment advice.